Neogen Corporation Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31)
Neogen Corporation (NEOG) reported Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) of $12.00 million for the 9-month period ending 2012-02-29, per its 10-Q filed 2012-03-30.
Discontinued › Notes
us-gaap:LineOfCreditFacilityIncreaseAdditionalBorrowings · last filed 2012-03-30
- Neogen Corporation line of credit facility, increase, additional borrowings (deprecated 2013-01-31) for the quarter ending 2012-02-29 was $0.00.
- Neogen Corporation line of credit facility, increase, additional borrowings (deprecated 2013-01-31) for the quarter ending 2010-08-31 was $2.00M.
| Period end | Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) 3 month | Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) 6 month | Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) 9 month |
|---|---|---|---|
| 2012-02-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $12.00M 10-Q · filed 2012-03-30 | |
| 2011-11-30 | $12.00M 10-Q · filed 2011-12-30 | ||
| 2010-08-31 | $2.00M 10-Q · filed 2011-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |